As filed with the Securities and Exchange Commission on August 7, 2019
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-3
REGISTRATION STATEMENT
UNDER
THE
SECURITIES ACT OF 1933
Portola Pharmaceuticals, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
Delaware
|
|
20-0216859
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification Number)
|
270 E. Grand Ave.
South
San Francisco, CA 94080
(650) 246-7300
(Address, including zip code, and telephone number, including area code, of registrants principal executive offices)
Scott Garland
President
and Chief Executive Officer
John Moriarty
Executive Vice President and General Counsel
Portola Pharmaceuticals, Inc.
270 E. Grand Ave.
South
San Francisco, CA 94080
(650) 246-7300
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
Kenneth
L. Guernsey
Sally A. Kay
Cooley LLP
101 California
Street, 5
th
Floor
San Francisco, CA 94111
(415)
693-2000
From time to
time after the effective date of this Registration Statement
(Approximate date of commencement of proposed sale to the public)
If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the
following box: ☐
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis
pursuant to Rule 415 under the Securities Act of 1933, as amended, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box: ☒
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the
following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering: ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If
this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following
box. ☒
If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D.
filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐